Bristol-Myers Squibb Stock Prediction and Forecast [BMY]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 03 Oct 2025, 03:59 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Bristol-Myers Squibb Stock Prediction and Forecast [BMY]](https://i.ytimg.com/vi/6LE_OFMdAUU/hqdefault.jpg)
AI-generated source summary
The video presents a bearish outlook for Bristol-Myers Squibb (BMY). On October 2nd, 2025, the system ranked it as a sell candidate, with a score of -3.82. The stock is in a declining trend in the short term, with a potential decrease of 3.7% over the next three months. The trading levels indicate the weekly volatility is 3.51%, and a first support at $45.10 is expected. If it’s broken, further declines are anticipated. Elkins David V had a sell of 56,000 shares of common stock with par value of $0.10, Short Bartie Wendy buy of 1,235 shares, Short Bartie Wendy sell of 632 shares, Short Bartie Wendy sell of 1,235 shares and Massacesi Cristian buy of 204,691 shares. The stock expected to open up $0.540 and start trading at $46.27.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.